The rise in cell and gene therapy sector

As per the new report from the Cell and Gene Therapy Catapult (CGT Catapult) showed there is a growth in the employment for cell and gene therapy sectors. A report showing that the industry currently offers over 3,000 jobs, with 1,700 roles in manufacturing and bioprocessing.

By 2024, the UK is expected to double the employment in the cell and gene sector because more treatments are moving towards commercialization. This clearly proves that in the last seven years, the sector has reached from 500 jobs in 2012 to over 3,000, and is expected to reach over 6,000 jobs by 2024.

Good Manufacturing Practice (GMP) manufacturing report, in addition to its skills, demand report, shows that in addition to the employment figures, the manufacturing sector in academia and industry is also growing for the fifth consecutive year, with facilities rapidly becoming operational. Manufacturing capacity specifically in the UK is due to increase even further in 2020 – principally from Oxford Biomedica and the expansion of the CGT Catapult.

Keith Thompson, the catapult’s chief executive officer also said the progress has been hailed as “encouraging”. He also said that the advanced treatments are progressing from research into becoming business commercial products. Continuous support from Innovate UK and UK Research and Innovation, sector have been able to accelerate the growth of the UK ecosystem, the infrastructures and the systems that can enable businesses to grow and for their treatments to reach patients.

He also expressed that the industry is in need of many more skilled people to keep growing and the expansion of programs such as the Advanced Therapies Apprenticeship Community (ATAC) is an essential part of this.

Related Posts

  • Health
  • July 23, 2025
  • 153 views
10, 000 Km is just a Number for Intercontinental Tele Surgery by SSIMantra

‘Made in India’ Surgical Robot does a Trailblazer between India & France France/ India: Two continents as it were shrunk to an operation theatre, thanks to Made in India surgical…

  • Health
  • July 18, 2025
  • 818 views
Bihar Healthcare is poised to be embraced by Robotic Surgery Mantra

Prodigal ‘Surgeon’ Son returns from London to put Bihar on Robotic Surgery Map New Delhi: Bihar healthcare may be on the cusp of being cutting edge as prospect of its…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Natco Pharma shares dip over 2% after Rs 2,000-crore stake buy in South Africa’s Adcock Ingram

Natco Pharma shares dip over 2% after Rs 2,000-crore stake buy in South Africa’s Adcock Ingram

10, 000 Km is just a Number for Intercontinental Tele Surgery by SSIMantra

10, 000 Km is just a Number for Intercontinental Tele Surgery by SSIMantra

DGFT Extends Deadline on Application for Export of Pharma Grade Sugar

DGFT Extends Deadline on Application for Export of Pharma Grade Sugar

Bihar Healthcare is poised to be embraced by Robotic Surgery Mantra

Bihar Healthcare is poised to be embraced by Robotic Surgery Mantra